Background
thrombosis, myocardial infarction
THROMBOSIS, ADVERSE EFFECTS, MYOCARDIAL INFARCTION
Academic Editor: Alessandro Sciahbasi Dual antiplatelet therapy with a P2Y12 inhibitor (e.g., clopidogrel and ticagrelor) and aspirin is recommended for at least one year after percutaneous coronary intervention (PCI) to prevent further myocardial infarction and stent thrombosis as the major adverse effects of PCI. 